Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.19 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.71.
Market Cap
9.19T
Revenue
4.66T
Profits
184.93B
PE Ratio
49.71
Profit Margin
3.97%
Dividend Yield
0.38%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -0.52% | 2,898,530 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 624.74B | 0.88% | 6,533,525 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 434.78B | 0.89% | 4,930,646 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 369.69B | 0.77% | 4,096,597 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 317.57B | 0.16% | 7,349,247 | 66.57B |
| 6 | NVS | Novartis AG | 296.43B | 1.37% | 1,309,112 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 248.99B | 0.88% | 3,720,556 | 61.37B |
| 8 | AMGN | Amgen Inc. | 222.17B | 1.51% | 1,795,558 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 219.63B | 2.41% | 2,206,675 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 208.61B | 2.81% | 12,079,425 | 50.34B |
| 11 | ABT | Abbott Laboratories | 186.55B | -0.14% | 6,606,576 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 165.17B | 1.80% | 8,201,905 | 30.46B |
| 13 | PFE | Pfizer Inc. | 152.52B | 2.14% | 42,742,171 | 63.70B |
| 14 | DHR | Danaher Corporation | 143.94B | 2.39% | 3,323,841 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 133.83B | 1.36% | 2,465,651 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 132.20B | 0.89% | 7,212,855 | 49.19B |
| 17 | SYK | Stryker Corporation | 130.04B | 0.47% | 1,845,884 | 25.84B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 125.73B | 2.49% | 992,492 | 12.59B |
| 19 | CVS | CVS Health Corporation | 122.40B | -0.54% | 12,403,395 | 412.65B |
| 20 | MDT | Medtronic plc | 111.57B | 1.44% | 5,056,457 | 36.36B |
| 21 | GSK | GSK plc | 106.01B | 1.51% | 2,522,113 | 44.05B |
| 22 | SNY | Sanofi | 104.31B | 1.33% | 2,766,259 | 55.89B |
| 23 | MCK | McKesson Corporation | 101.38B | -0.21% | 1,625,396 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 89.49B | 1.09% | 1,071,791 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.49B | 0.72% | 942,123 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.32B | 1.59% | 716,779 | 15.53B |
| 27 | CI | The Cigna Group | 74.65B | 2.63% | 2,289,089 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.46B | 0.02% | 11,447,002 | 21.00B |
| 29 | COR | Cencora, Inc. | 61.15B | -1.40% | 1,560,529 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.09B | 2.53% | 4,253,812 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 55.37B | -0.53% | 1,551,067 | 250.74B |
| 32 | ARGX | argenx SE | 55.18B | -1.17% | 249,977 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 51.71B | 0.45% | 2,441,823 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 48.17B | -0.12% | 1,851,973 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.32B | 2.09% | 8,337,922 | 29.94B |
| 36 | NTRA | Natera, Inc. | 46.26B | 21.37% | 3,386,662 | 2.71B |
| 37 | HUM | Humana Inc. | 46.23B | 4.84% | 1,405,093 | 145.68B |
| 38 | IDXX | IDEXX Laboratories, Inc. | 46.22B | -0.56% | 589,392 | 4.55B |
| 39 | HLN | Haleon plc | 43.91B | - | 5,493,338 | 14.80B |
| 40 | RVMD | Revolution Medicines, Inc. | 43.61B | 3.71% | 1,665,031 | - |
| 41 | A | Agilent Technologies, Inc. | 41.23B | 3.28% | 1,525,215 | 7.23B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 41.20B | 1.58% | 4,271,825 | 17.32B |
| 43 | WAT | Waters Corporation | 39.95B | 1.79% | 891,257 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 39.60B | 5.60% | 638,193 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 39.29B | 2.70% | 1,086,329 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 37.44B | 5.82% | 2,565,899 | 3.32B |
| 47 | ALC | Alcon Inc. | 34.62B | 3.26% | 2,181,907 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 32.64B | -0.86% | 3,805,447 | 2.54B |
| 49 | CNC | Centene Corporation | 32.49B | 2.45% | 3,526,226 | 180.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.42B | 2.08% | 2,938,744 | 21.27B |
| 51 | DXCM | DexCom, Inc. | 31.98B | 2.08% | 4,580,582 | 4.97B |
| 52 | BIIB | Biogen Inc. | 30.72B | 0.80% | 814,376 | 10.03B |
| 53 | RMD | ResMed Inc. | 30.57B | -5.06% | 3,810,438 | 5.65B |
| 54 | ZTS | Zoetis Inc. | 30.02B | -5.97% | 12,784,553 | 9.53B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.33B | 1.43% | 1,702,556 | 4.80B |
| 56 | MTD | Mettler-Toledo International Inc. | 28.64B | 0.58% | 123,700 | 4.13B |
| 57 | INSM | Insmed Incorporated | 28.63B | -1.09% | 4,904,625 | 1.14B |
| 58 | ILMN | Illumina, Inc. | 28.38B | -2.97% | 1,819,050 | 4.49B |
| 59 | DGX | Quest Diagnostics Incorporated | 26.31B | -0.06% | 576,519 | 11.56B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.25B | 3.47% | 6,670,885 | 7.53M |
| 61 | PHG | Koninklijke Philips N.V. | 26.14B | 1.52% | 729,422 | 20.18B |
| 62 | LH | Labcorp Holdings Inc. | 25.88B | 0.83% | 429,350 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.92B | 1.57% | 500,738 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.44B | 1.84% | 1,540,363 | 5.82B |
| 65 | MRNA | Moderna, Inc. | 23.62B | 9.86% | 6,820,582 | 2.23B |
| 66 | BNTX | BioNTech SE | 23.53B | 2.72% | 1,427,587 | 3.03B |
| 67 | STE | STERIS plc | 23.14B | 2.45% | 804,014 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 23.11B | 1.11% | 973,792 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.61B | 6.92% | 2,193,758 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.11B | 2.14% | 626,193 | 21.81B |
| 71 | VTRS | Viatris Inc. | 18.87B | 0.86% | 13,015,341 | 14.74B |
| 72 | GMAB | Genmab A/S | 18.45B | 4.66% | 3,507,124 | 4.13B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.42B | -0.66% | 2,186,660 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 16.84B | 2.23% | 325,549 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 16.65B | -0.04% | 970,710 | 4.60B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.61B | 2.25% | 970,859 | 3.37B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.51B | 2.03% | 2,148,200 | 579.96M |
| 78 | MEDP | Medpace Holdings, Inc. | 16.49B | 0.97% | 136,482 | 2.78B |
| 79 | COO | The Cooper Companies, Inc. | 14.48B | 1.24% | 1,561,957 | 4.23B |
| 80 | BAX | Baxter International Inc. | 14.24B | 2.00% | 8,192,691 | 11.47B |
| 81 | SOLV | Solventum Corporation | 14.13B | 0.02% | 1,104,147 | 8.31B |
| 82 | EXEL | Exelixis, Inc. | 13.40B | 3.58% | 3,549,965 | 2.44B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.06B | 3.02% | 2,165,085 | 14.37B |
| 84 | FMS | Fresenius Medical Care AG | 12.88B | 0.71% | 950,512 | 22.19B |
| 85 | RVTY | Revvity, Inc. | 12.79B | 0.37% | 1,050,532 | 2.91B |
| 86 | PEN | Penumbra, Inc. | 12.79B | -0.06% | 239,512 | 1.50B |
| 87 | CRL | Charles River Laboratories International, Inc. | 12.77B | 0.75% | 612,507 | 4.00B |
| 88 | ICLR | ICON Public Limited Company | 12.69B | 2.07% | 388,372 | 8.29B |
| 89 | SNN | Smith & Nephew plc | 12.63B | 1.41% | 1,518,603 | 6.30B |
| 90 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.38B | 2.12% | 948,140 | 669.50M |
| 91 | EHC | Encompass Health Corporation | 12.37B | 0.33% | 954,713 | 6.21B |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 12.35B | 3.82% | 4,364,508 | 3.41B |
| 93 | ALGN | Align Technology, Inc. | 12.34B | 2.71% | 887,369 | 4.14B |
| 94 | CORT | Corcept Therapeutics Incorporated | 11.97B | 2.61% | 769,035 | 830.81M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.78B | -0.06% | 347,529 | 1.28B |
| 96 | DVA | DaVita Inc. | 11.72B | 1.72% | 1,244,913 | 14.01B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.70B | 20.24% | 7,833,817 | 1.66B |
| 98 | ABVX | ABIVAX Société Anonyme | 11.37B | 0.72% | 1,100,265 | 5.67M |
| 99 | TECH | Bio-Techne Corporation | 11.26B | 0.54% | 5,577,377 | 1.21B |
| 100 | SMMT | Summit Therapeutics Inc. | 11.14B | 3.10% | 2,180,961 | - |
| 101 | GMED | Globus Medical, Inc. | 11.06B | 1.57% | 3,299,671 | 3.14B |
| 102 | ELAN | Elanco Animal Health Incorporated | 11.05B | -8.60% | 22,076,713 | 5.02B |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.95B | 1.24% | 1,023,411 | 708.24M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.67B | -5.67% | 3,604,382 | 67.67M |
| 105 | GKOS | Glaukos Corporation | 10.61B | 5.28% | 768,789 | 612.84M |
| 106 | ENSG | The Ensign Group, Inc. | 10.57B | 0.72% | 290,952 | 5.49B |
| 107 | UHS | Universal Health Services, Inc. | 10.51B | 2.25% | 413,374 | 18.11B |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 10.26B | 0.91% | 2,564,066 | 3.50B |
| 109 | MOH | Molina Healthcare, Inc. | 10.23B | 2.38% | 438,163 | 42.47B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.12B | 0.26% | 1,490,074 | - |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.06B | -2.54% | 454,827 | 7.46M |
| 112 | HSIC | Henry Schein, Inc. | 9.82B | -0.08% | 642,623 | 13.60B |
| 113 | PODD | Insulet Corporation | 9.79B | 1.34% | 1,591,344 | 3.05B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.66B | 1.17% | 160,022 | 440.48M |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 9.42B | 2.93% | 266,853 | 2.59B |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.40B | 3.80% | 2,009,200 | 874.09M |
| 117 | TEM | Tempus AI, Inc. | 9.39B | 12.86% | 5,692,866 | 1.43B |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.38B | -0.21% | 321,055 | 281.99M |
| 119 | SYRE | Spyre Therapeutics, Inc. | 9.25B | 1.44% | 526,560 | - |
| 120 | RGEN | Repligen Corporation | 9.25B | 2.80% | 950,494 | 785.10M |
| 121 | AVTR | Avantor, Inc. | 9.19B | 3.11% | 6,218,141 | 6.56B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 8.94B | 1.04% | 463,568 | 105.00M |
| 123 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.92B | 0.19% | 1,941,775 | 42.16M |
| 124 | QGEN | Qiagen N.V. | 8.75B | 1.37% | 3,796,107 | 2.10B |
| 125 | HQY | HealthEquity, Inc. | 8.75B | 1.15% | 515,582 | 1.34B |
| 126 | ATR | AptarGroup, Inc. | 8.61B | -0.27% | 696,292 | 3.93B |
| 127 | OSCR | Oscar Health, Inc. | 8.60B | 5.12% | 10,579,467 | 15.32B |
| 128 | PCVX | Vaxcyte, Inc. | 8.39B | -1.39% | 1,296,245 | - |
| 129 | ALKS | Alkermes plc | 8.25B | 1.65% | 972,735 | 1.67B |
| 130 | IMVT | Immunovant, Inc. | 8.25B | 0.53% | 906,297 | - |
| 131 | BRKR | Bruker Corporation | 8.14B | 4.17% | 2,063,365 | 3.50B |
| 132 | IBRX | ImmunityBio, Inc. | 8.10B | 4.37% | 9,390,077 | 165.79M |
| 133 | LQDA | Liquidia Corporation | 8.02B | 0.89% | 562,006 | 288.07M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.96B | 3.15% | 672,760 | 239.92M |
| 135 | PACS | PACS Group, Inc. | 7.67B | 3.79% | 968,638 | 5.55B |
| 136 | HIMS | Hims & Hers Health, Inc. | 7.31B | 6.51% | 8,391,220 | 2.37B |
| 137 | TWST | Twist Bioscience Corporation | 7.25B | 6.04% | 1,561,406 | 431.80M |
| 138 | COGT | Cogent Biosciences, Inc. | 7.24B | 1.41% | 1,855,577 | - |
| 139 | CHE | Chemed Corporation | 7.19B | 0.60% | 154,045 | 2.60B |
| 140 | TGTX | TG Therapeutics, Inc. | 7.06B | 0.42% | 1,768,420 | 799.54M |
| 141 | GRFS | Grifols, S.A. | 7.05B | 1.40% | 400,481 | 8.48B |
| 142 | HNGE | Hinge Health, Inc. | 6.91B | 11.55% | 2,562,855 | 720.06M |
| 143 | CGON | CG Oncology, Inc. | 6.62B | 0.33% | 611,586 | 6.23M |
| 144 | TXG | 10x Genomics, Inc. | 6.61B | 14.10% | 5,434,070 | 616.91M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.59B | -0.12% | 2,079,488 | 1.56B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.54B | 6.94% | 838,968 | 618.07M |
| 147 | CAI | Caris Life Sciences, Inc. | 6.43B | 13.70% | 9,399,425 | 989.61M |
| 148 | BLTE | Belite Bio, Inc | 6.41B | 1.48% | 126,411 | - |
| 149 | ERAS | Erasca, Inc. | 6.39B | 0.77% | 2,096,111 | - |
| 150 | SRRK | Scholar Rock Holding Corporation | 6.34B | 0.53% | 958,335 | - |
| 151 | DFTX | Definium Therapeutics, Inc. | 6.12B | - | 2,546,997 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 6.12B | -1.84% | 720,233 | 7.50M |
| 153 | PTCT | PTC Therapeutics, Inc. | 6.12B | 3.47% | 951,261 | 1.01B |
| 154 | DNTH | Dianthus Therapeutics, Inc. | 6.09B | -0.91% | 570,168 | 1.90M |
| 155 | BLCO | Bausch + Lomb Corporation | 5.99B | 2.63% | 257,664 | 5.32B |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.96B | 0.41% | 308,654 | - |
| 157 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.93B | -0.59% | 219,774 | 840.85M |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.81B | -2.33% | 291,188 | 290.54M |
| 159 | AMRX | Amneal Pharmaceuticals, Inc. | 5.79B | 0.39% | 1,089,967 | 3.12B |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.78B | -1.81% | 1,226,432 | 591.33M |
| 161 | TFX | Teleflex Incorporated | 5.72B | -2.82% | 752,283 | 2.25B |
| 162 | RDNT | RadNet, Inc. | 5.69B | 6.20% | 1,470,214 | 2.14B |
| 163 | STVN | Stevanato Group S.p.A. | 5.53B | -0.10% | 306,404 | 1.40B |
| 164 | MMED | MiniMed Group, Inc. | 5.50B | 6.41% | 1,629,884 | 3.10B |
| 165 | SHC | Sotera Health Company | 5.38B | -0.26% | 3,374,632 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.32B | 1.54% | 1,146,809 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.17B | 3.64% | 1,284,025 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.03B | 2.67% | 1,781,855 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.90B | 1.43% | 1,990,980 | - |
| 170 | DOCS | Doximity, Inc. | 4.88B | 32.62% | 65,387,095 | 655.57M |
| 171 | MANE | Veradermics, Incorporated | 4.78B | 5.28% | 542,265 | - |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.68B | -2.03% | 1,478,270 | - |
| 173 | WAY | Waystar Holding Corp. | 4.65B | 3.68% | 4,669,366 | 1.21B |
| 174 | ICUI | ICU Medical, Inc. | 4.61B | 10.93% | 931,222 | 2.16B |
| 175 | INDV | Indivior Pharmaceuticals, Inc. | 4.58B | 0.39% | 1,686,993 | 1.33B |
| 176 | CELC | Celcuity Inc. | 4.52B | -0.50% | 542,809 | - |
| 177 | NVST | Envista Holdings Corporation | 4.52B | 2.81% | 4,070,973 | 2.86B |
| 178 | PBLS | Parabilis Medicines, Inc. | 4.45B | -1.69% | 279,759 | - |
| 179 | BLLN | BillionToOne, Inc. | 4.41B | 1.90% | 1,530,328 | 397.41M |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.36B | 11.53% | 2,037,661 | 2.29B |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.31B | 0.10% | 2,314,901 | 10.35M |
| 182 | ITGR | Integer Holdings Corporation | 4.26B | -0.63% | 1,055,803 | 1.84B |
| 183 | ELVN | Enliven Therapeutics, Inc. | 4.22B | 0.32% | 696,061 | - |
| 184 | IRTC | iRhythm Holdings, Inc. | 4.21B | -0.22% | 1,827,515 | 825.34M |
| 185 | LIVN | LivaNova PLC | 4.20B | 0.58% | 744,982 | 1.47B |
| 186 | LFST | LifeStance Health Group, Inc. | 4.14B | 1.69% | 3,793,298 | 1.58B |
| 187 | LEGN | Legend Biotech Corporation | 4.01B | 7.62% | 2,610,748 | 1.14B |
| 188 | VKTX | Viking Therapeutics, Inc. | 4.00B | 2.88% | 1,402,492 | - |
| 189 | HAE | Haemonetics Corporation | 4.00B | 3.32% | 657,074 | 1.35B |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.98B | 5.64% | 2,494,979 | 308.08M |
| 191 | DNLI | Denali Therapeutics Inc. | 3.94B | 0.40% | 1,750,014 | 3.60M |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.92B | -6.66% | 3,231,205 | 56.99M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.89B | 8.27% | 212,702 | 803.79M |
| 194 | VCYT | Veracyte, Inc. | 3.80B | 2.32% | 787,622 | 561.90M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.78B | 0.99% | 329,338 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.64B | 1.02% | 1,061,511 | 117.00M |
| 197 | IDYA | IDEAYA Biosciences, Inc. | 3.57B | 2.15% | 602,270 | 234.13M |
| 198 | OGN | Organon & Co. | 3.57B | 0.37% | 3,332,592 | 6.13B |
| 199 | OPCH | Option Care Health, Inc. | 3.56B | 0.68% | 3,898,078 | 5.69B |
| 200 | ALMS | Alumis Inc. | 3.52B | -0.72% | 782,673 | 8.40M |
| 201 | BKD | Brookdale Senior Living Inc. | 3.40B | -0.97% | 4,052,116 | 3.00B |
| 202 | NHC | National HealthCare Corporation | 3.38B | -1.78% | 128,712 | 1.56B |
| 203 | CLDX | Celldex Therapeutics, Inc. | 3.27B | 0.46% | 808,911 | 158.00K |
| 204 | WRBY | Warby Parker Inc. | 3.27B | -1.85% | 5,748,104 | 911.61M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | 1.05% | 572,003 | 7.12M |
| 206 | MBX | MBX Biosciences, Inc. | 3.23B | 1.06% | 545,470 | - |
| 207 | QURE | uniQure N.V. | 3.22B | 2.34% | 1,827,795 | 18.67M |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -4.31% | 2,448,556 | 463.98M |
| 209 | GRAL | GRAIL, Inc. | 3.10B | 9.59% | 1,643,780 | 165.26M |
| 210 | ALHC | Alignment Healthcare, Inc. | 2.98B | 7.40% | 5,674,509 | 4.58B |
| 211 | IRON | Disc Medicine, Inc. | 2.97B | -0.14% | 307,548 | - |
| 212 | ACHC | Acadia Healthcare Company, Inc. | 2.94B | 2.64% | 1,181,900 | 3.37B |
| 213 | PLSE | Pulse Biosciences, Inc. | 2.94B | 10.90% | 734,090 | 1.19M |
| 214 | TMDX | TransMedics Group, Inc. | 2.91B | 4.59% | 772,369 | 668.47M |
| 215 | IOVA | Iovance Biotherapeutics, Inc. | 2.87B | 2.09% | 30,970,672 | 324.97M |
| 216 | PRVA | Privia Health Group, Inc. | 2.87B | 2.05% | 2,287,955 | 2.36B |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.84B | -0.83% | 983,149 | 606.33M |
| 218 | IMNM | Immunome, Inc. | 2.83B | -3.06% | 772,555 | 4.02M |
| 219 | KOD | Kodiak Sciences Inc. | 2.83B | -0.07% | 511,436 | - |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.78B | 11.05% | 1,045,087 | 1.46B |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.77B | 1.88% | 702,615 | 830.44M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.75B | 0.84% | 1,323,930 | 156.04M |
| 223 | ATAI | AtaiBeckley Inc. | 2.68B | 0.97% | 6,407,456 | 3.49M |
| 224 | RGC | Regencell Bioscience Holdings Limited | 2.68B | -0.92% | 191,881 | - |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.23% | 729,851 | 36.77M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 0.05% | 2,194,680 | - |
| 227 | ZLAB | Zai Lab Limited | 2.62B | 11.69% | 2,046,120 | 449.61M |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.60B | 4.80% | 1,659,798 | 71.13M |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.60B | 0.77% | 597,746 | 1.10B |
| 230 | PGEN | Precigen, Inc. | 2.59B | 4.63% | 5,758,900 | 85.72M |
| 231 | NKTR | Nektar Therapeutics | 2.58B | 4.13% | 899,043 | 55.63M |
| 232 | RARE | Ultragenyx Pharmaceutical Inc. | 2.55B | 0.35% | 3,808,975 | 717.00M |
| 233 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.54B | -5.66% | 2,678,300 | -665.00K |
| 234 | CLOV | Clover Health Investments, Corp. | 2.52B | 2.15% | 7,673,360 | 2.48B |
| 235 | NEOG | Neogen Corporation | 2.50B | 1.46% | 1,520,335 | 870.40M |
| 236 | AXGN | Axogen, Inc. | 2.50B | 4.69% | 712,914 | 251.17M |
| 237 | HTFL | HeartFlow, Inc. | 2.49B | 5.99% | 746,207 | 191.42M |
| 238 | PHVS | Pharvaris N.V. | 2.44B | 1.34% | 696,380 | - |
| 239 | UFPT | UFP Technologies, Inc. | 2.43B | 0.72% | 132,755 | 631.64M |
| 240 | KLRA | Kailera Therapeutics, Inc. | 2.42B | -1.11% | 276,237 | - |
| 241 | XRAY | DENTSPLY SIRONA Inc. | 2.42B | -7.97% | 8,574,060 | 3.64B |
| 242 | CDNA | CareDx, Inc. | 2.42B | 4.20% | 965,421 | 458.09M |
| 243 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 1.33% | 386,166 | - |
| 244 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.40B | 0.86% | 4,383,147 | 940.61M |
| 245 | SLS | SELLAS Life Sciences Group, Inc. | 2.36B | 2.65% | 5,124,094 | - |
| 246 | VERA | Vera Therapeutics, Inc. | 2.36B | 2.72% | 1,515,195 | - |
| 247 | BFLY | Butterfly Network, Inc. | 2.35B | 6.39% | 4,901,471 | 112.14M |
| 248 | BHC | Bausch Health Companies Inc. | 2.34B | 5.75% | 4,231,755 | 10.85B |
| 249 | COAG | Hemab Therapeutics Holdings, Inc. | 2.32B | -4.79% | 415,712 | - |
| 250 | NUVB | Nuvation Bio Inc. | 2.32B | 8.02% | 5,777,358 | 169.90M |
| 251 | VCEL | Vericel Corporation | 2.31B | 0.63% | 443,885 | 306.30M |
| 252 | SION | Sionna Therapeutics, Inc. | 2.30B | 2.88% | 747,526 | - |
| 253 | WGS | GeneDx Holdings Corp. | 2.30B | 10.76% | 1,068,585 | 454.43M |
| 254 | URGN | UroGen Pharma Ltd. | 2.30B | 2.98% | 1,026,471 | 188.73M |
| 255 | ESTA | Establishment Labs Holdings Inc. | 2.28B | -2.06% | 754,093 | 245.82M |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.27B | 1.83% | 182,279 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -0.88% | 994,522 | 959.90M |
| 258 | ADMA | ADMA Biologics, Inc. | 2.22B | -1.59% | 3,305,138 | 512.28M |
| 259 | BHVN | Biohaven Ltd. | 2.21B | 1.66% | 1,121,813 | - |
| 260 | ADUS | Addus HomeCare Corporation | 2.19B | 0.67% | 153,259 | 1.48B |
| 261 | RAPP | Rapport Therapeutics, Inc. | 2.18B | -1.86% | 246,052 | 20.00M |
| 262 | HCM | HUTCHMED (China) Limited | 2.16B | 5.92% | 43,352 | 549.12M |
| 263 | PGNY | Progyny, Inc. | 2.16B | -6.98% | 3,185,064 | 1.31B |
| 264 | MD | Pediatrix Medical Group, Inc. | 2.15B | 2.15% | 898,463 | 1.95B |
| 265 | NEO | NeoGenomics, Inc. | 2.13B | 6.49% | 1,346,624 | 766.30M |
| 266 | ABCL | AbCellera Biologics Inc. | 2.12B | 6.13% | 6,822,768 | 66.17M |
| 267 | STOK | Stoke Therapeutics, Inc. | 2.11B | 2.44% | 866,577 | 27.59M |
| 268 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -1.74% | 1,545,125 | 311.51M |
| 269 | ATRC | AtriCure, Inc. | 2.11B | 4.87% | 527,759 | 569.62M |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 3.47% | 1,929,723 | 7.47M |
| 271 | GHRS | GH Research PLC | 2.08B | -1.21% | 337,142 | - |
| 272 | AVAH | Aveanna Healthcare Holdings Inc. | 2.07B | 1.93% | 1,172,482 | 2.52B |
| 273 | MESO | Mesoblast Limited | 2.05B | 2.18% | 80,929 | 65.38M |
| 274 | ZBIO | Zenas BioPharma, Inc. | 2.05B | 0.81% | 263,866 | 10.00M |
| 275 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 5.15% | 2,016,573 | 52.06M |
| 276 | SGRY | Surgery Partners, Inc. | 2.01B | 4.09% | 1,892,619 | 3.34B |
| 277 | ALMR | Alamar Biosciences, Inc. | 1.97B | 1.28% | 135,243 | 87.16M |
| 278 | NBTX | Nanobiotix S.A. | 1.96B | 1.14% | 107,384 | 38.27M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 1.00% | 1,178,848 | 98.34M |
| 280 | BRVE | Braveheart Bio, Inc. | 1.93B | 0.67% | 566,321 | - |
| 281 | NVCR | NovoCure Limited | 1.91B | 4.46% | 1,529,194 | 699.19M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.88B | -0.15% | 316,869 | 367.34M |
| 283 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.05% | 1,056,673 | - |
| 284 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 0.78% | 374,412 | 262.43M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.84B | 2.00% | 570,507 | - |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.84B | 0.13% | 197,354 | - |
| 287 | GENB | Generate Biomedicines, Inc. | 1.84B | 3.31% | 505,790 | 26.48M |
| 288 | KARD | Kardigan, Inc. | 1.83B | 0.69% | 160,029 | - |
| 289 | CMPS | COMPASS Pathways plc | 1.83B | -0.07% | 3,393,413 | - |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | 3.24% | 1,188,303 | 252.25M |
| 291 | PRGO | Perrigo Company plc | 1.78B | 2.39% | 2,107,040 | 4.14B |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.78B | 3.33% | 139,062 | 1.20B |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | - | 3,064,108 | 1.97B |
| 294 | ASTH | Astrana Health, Inc. | 1.76B | 4.78% | 909,830 | 3.84B |
| 295 | FTRE | Fortrea Holdings Inc. | 1.75B | 4.18% | 989,727 | 2.68B |
| 296 | SEPN | Septerna, Inc. | 1.75B | -1.77% | 274,144 | 72.26M |
| 297 | INSP | Inspire Medical Systems, Inc. | 1.74B | 2.16% | 538,893 | 898.74M |
| 298 | IMCR | Immunocore Holdings plc | 1.73B | -1.36% | 492,085 | 430.78M |
| 299 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | 1.26% | 9,355,889 | 54.86M |
| 300 | AAPG | Ascentage Pharma Group International | 1.71B | 11.09% | 8,680 | 82.08M |
| 301 | OBX | Obsidian Therapeutics, Inc. | 1.70B | -3.00% | 8,857 | - |
| 302 | BLFS | BioLife Solutions, Inc. | 1.70B | 2.15% | 655,841 | 106.69M |
| 303 | ZYME | Zymeworks Inc. | 1.69B | 1.77% | 546,559 | 37.13M |
| 304 | TRLV | Trulieve Cannabis Corp. | 1.68B | -2.78% | 1,041,299 | 1.14B |
| 305 | OMCL | Omnicell, Inc. | 1.68B | 1.80% | 754,883 | 1.25B |
| 306 | ANAB | AnaptysBio, Inc. | 1.68B | 3.36% | 536,732 | 232.39M |
| 307 | NTLA | Intellia Therapeutics, Inc. | 1.67B | 6.23% | 4,937,181 | 59.51M |
| 308 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | -5.30% | 1,019,883 | 978.38M |
| 309 | ARDT | Ardent Health, Inc. | 1.64B | -0.35% | 339,802 | 6.41B |
| 310 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | -0.32% | 4,077,469 | 208.78M |
| 311 | AGL | agilon health, inc. | 1.60B | 10.00% | 540,340 | 5.92B |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.59B | 0.42% | 480,729 | 20.00M |
| 313 | TYRA | Tyra Biosciences, Inc. | 1.58B | -1.67% | 820,623 | - |
| 314 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | 0.04% | 629,281 | - |
| 315 | XNCR | Xencor, Inc. | 1.55B | 4.05% | 1,124,577 | 104.97M |
| 316 | KMTS | Kestra Medical Technologies, Ltd. | 1.55B | 4.47% | 275,724 | 95.13M |
| 317 | ENOV | Enovis Corporation | 1.53B | 1.14% | 2,058,435 | 2.30B |
| 318 | TNDM | Tandem Diabetes Care, Inc. | 1.53B | 19.11% | 5,435,937 | 1.04B |
| 319 | HCSG | Healthcare Services Group, Inc. | 1.53B | 0.82% | 786,239 | 1.86B |
| 320 | INNV | InnovAge Holding Corp. | 1.52B | 1.82% | 336,369 | 949.17M |
| 321 | ABSI | Absci Corporation | 1.51B | 7.59% | 2,193,432 | 1.84M |
| 322 | PSNL | Personalis, Inc. | 1.51B | 8.67% | 3,211,584 | 69.67M |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.51B | 1.28% | 902,055 | - |
| 324 | HROW | Harrow, Inc. | 1.51B | 1.30% | 322,804 | 268.68M |
| 325 | AVLN | Avalyn Pharma Inc. | 1.50B | 3.73% | 120,903 | - |
| 326 | VIR | Vir Biotechnology, Inc. | 1.49B | 0.57% | 1,663,110 | 303.23M |
| 327 | INVA | Innoviva, Inc. | 1.48B | -2.84% | 1,143,223 | 440.00M |
| 328 | SVRA | Savara Inc. | 1.48B | 0.69% | 1,586,202 | - |
| 329 | CNMD | CONMED Corporation | 1.47B | -1.31% | 434,404 | 1.37B |
| 330 | XERS | Xeris Biopharma Holdings, Inc. | 1.45B | 7.74% | 2,253,118 | 335.41M |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.44B | 1.09% | 2,489,966 | 815.05M |
| 332 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -0.55% | 302,081 | - |
| 333 | OMDA | Omada Health, Inc. | 1.43B | 21.14% | 4,850,920 | 309.76M |
| 334 | AZTA | Azenta, Inc. | 1.40B | 4.23% | 735,834 | 613.81M |
| 335 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 4.41% | 1,330,662 | - |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.40B | 16.88% | 1,517,149 | 3.43B |
| 337 | PAHC | Phibro Animal Health Corporation | 1.39B | -3.41% | 231,332 | 1.50B |
| 338 | LBRX | LB Pharmaceuticals Inc | 1.38B | -0.37% | 269,158 | - |
| 339 | PNTG | The Pennant Group, Inc. | 1.36B | -0.15% | 180,537 | 1.10B |
| 340 | ALVO | Alvotech | 1.36B | 0.26% | 342,026 | 562.04M |
| 341 | SDGR | Schrödinger, Inc. | 1.36B | 1.97% | 1,371,265 | 259.04M |
| 342 | IART | Integra LifeSciences Holdings Corporation | 1.34B | 0.88% | 637,394 | 1.65B |
| 343 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | 1.08% | 1,031,389 | 28.73M |
| 344 | AKTS | Aktis Oncology, Inc. | 1.33B | 2.94% | 154,636 | 8.28M |
| 345 | MNKD | MannKind Corporation | 1.32B | 5.66% | 5,048,092 | 393.63M |
| 346 | AORT | Artivion, Inc. | 1.32B | 2.07% | 1,081,660 | 471.47M |
| 347 | IMTX | Immatics N.V. | 1.32B | 2.44% | 309,302 | 43.00M |
| 348 | NVAX | Novavax, Inc. | 1.31B | 2.71% | 5,704,173 | 413.80M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.30B | -1.26% | 481,233 | - |
| 350 | INBX | Inhibrx Biosciences, Inc. | 1.30B | 3.35% | 407,403 | 1.30M |
| 351 | TDOC | Teladoc Health, Inc. | 1.30B | 6.74% | 4,762,310 | 2.49B |
| 352 | VOR | Vor Biopharma Inc. | 1.28B | -0.13% | 801,804 | - |
| 353 | SPTX | Seaport Therapeutics, Inc. | 1.26B | 2.30% | 112,371 | - |
| 354 | FRNM | Freenome, Inc. | 1.26B | 1.56% | 548,580 | 34.24M |
| 355 | CERT | Certara, Inc. | 1.25B | 0.86% | 2,381,459 | 421.75M |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.25B | -1.08% | 1,910,206 | 785.23M |
| 357 | ETON | Eton Pharmaceuticals, Inc. | 1.22B | -3.42% | 277,986 | 86.93M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.21B | 2.19% | 300,120 | 79.76M |
| 359 | STAA | STAAR Surgical Company | 1.21B | 4.71% | 809,300 | 290.38M |
| 360 | WVE | Wave Life Sciences Ltd. | 1.20B | 1.33% | 4,556,371 | 65.37M |
| 361 | EYPT | EyePoint, Inc. | 1.20B | 8.26% | 1,655,691 | 2.79M |
| 362 | USPH | U.S. Physical Therapy, Inc. | 1.19B | 4.70% | 272,032 | 804.27M |
| 363 | BVS | Bioventus Inc. | 1.19B | 1.04% | 939,431 | 581.85M |
| 364 | DRTS | Alpha Tau Medical Ltd. | 1.19B | 1.15% | 297,025 | - |
| 365 | IRMD | IRADIMED CORPORATION | 1.18B | 1.41% | 88,199 | 86.34M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | 0.43% | 1,370,029 | - |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | 1.90% | 1,761,973 | 337.34M |
| 368 | CRON | Cronos Group Inc. | 1.16B | 0.98% | 2,086,245 | 179.09M |
| 369 | AHG | Akso Health Group | 1.16B | 2.28% | 21,486 | 13.83M |
| 370 | IVA | Inventiva S.A. | 1.16B | 3.00% | 579,057 | 7.94M |
| 371 | LTGO | Latigo Biotherapeutics, Inc. | 1.15B | 1.39% | 3,303,862 | - |
| 372 | NUTX | Nutex Health Inc. | 1.12B | 6.67% | 294,757 | 846.72M |
| 373 | ANRO | Alto Neuroscience, Inc. | 1.11B | 0.70% | 336,431 | - |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | 1.22% | 445,947 | 1.03B |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.10B | 4.66% | 3,085,709 | 41.47M |
| 376 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | -1.23% | 361,727 | - |
| 377 | APMD | Apnimed, Inc. | 1.08B | -3.16% | 160,472 | 120.15M |
| 378 | SANA | Sana Biotechnology, Inc. | 1.06B | 3.23% | 2,153,476 | - |
| 379 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 2.12% | 757,195 | - |
| 380 | OPK | OPKO Health, Inc. | 1.02B | 3.79% | 2,699,962 | 587.90M |
| 381 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | -1.76% | 97,817 | 99.00K |
| 382 | REPL | Replimune Group, Inc. | 1.01B | -6.22% | 8,913,757 | - |
| 383 | PCRX | Pacira BioSciences, Inc. | 997.34M | -2.19% | 603,210 | 746.16M |
| 384 | ARDX | Ardelyx, Inc. | 988.12M | -17.86% | 20,070,394 | 450.89M |
| 385 | CSTL | Castle Biosciences, Inc. | 978.50M | 5.12% | 241,774 | 357.28M |
| 386 | GMRS | GMR Solutions Inc. | 977.61M | 3.37% | 451,618 | 5.83B |
| 387 | AVTX | Avalo Therapeutics, Inc. | 969.18M | -2.03% | 730,168 | 59.00K |
| 388 | JANX | Janux Therapeutics, Inc. | 966.60M | -1.55% | 625,334 | 24.00M |
| 389 | OMER | Omeros Corporation | 958.97M | 0.76% | 1,227,715 | 9.89M |
| 390 | COLL | Collegium Pharmaceutical, Inc. | 955.82M | 1.24% | 1,010,131 | 808.21M |
| 391 | GERN | Geron Corporation | 950.86M | -5.73% | 8,885,427 | 204.56M |
| 392 | ABUS | Arbutus Biopharma Corporation | 914.60M | 1.98% | 796,029 | 191.45M |
| 393 | GLAS | Glass House Brands Inc. | 908.48M | 4.65% | 457,793 | 177.68M |
| 394 | ANNX | Annexon, Inc. | 886.39M | -3.39% | 1,784,136 | - |
| 395 | AMPH | Amphastar Pharmaceuticals, Inc. | 883.82M | 4.90% | 1,300,741 | 730.02M |
| 396 | AURA | Aura Biosciences, Inc. | 881.29M | 3.50% | 538,188 | - |
| 397 | INMD | InMode Ltd. | 880.03M | 1.26% | 397,207 | 374.63M |
| 398 | TBPH | Theravance Biopharma, Inc. | 877.45M | 0.06% | 2,722,733 | 109.78M |
| 399 | DSGN | Design Therapeutics, Inc. | 875.52M | 1.60% | 418,867 | - |
| 400 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 7,090,405 | 245.73M |
| 401 | AVR | Anteris Technologies Global Corp. | 868.33M | 6.58% | 502,263 | 1.85M |
| 402 | ATTO | Attovia Therapeutics, Inc. | 867.90M | -1.03% | 237,906 | 1.35M |
| 403 | KURA | Kura Oncology, Inc. | 849.57M | 3.13% | 749,257 | 71.64M |
| 404 | SGP | SpyGlass Pharma, Inc. | 846.20M | 2.26% | 72,029 | - |
| 405 | HSTM | HealthStream, Inc. | 839.06M | 2.13% | 178,740 | 321.12M |
| 406 | QDEL | QuidelOrtho Corporation | 837.73M | -24.72% | 4,938,135 | 2.67B |
| 407 | SIBN | SI-BONE, Inc. | 834.07M | 2.59% | 297,225 | 213.60M |
| 408 | SLDB | Solid Biosciences Inc. | 825.99M | -3.67% | 1,054,878 | - |
| 409 | ACRS | Aclaris Therapeutics, Inc. | 825.41M | -2.96% | 2,388,047 | 8.22M |
| 410 | CLYM | Climb Bio, Inc. | 801.68M | - | 910,241 | - |
| 411 | MNPR | Monopar Therapeutics Inc. | 798.56M | -0.83% | 223,297 | - |
| 412 | DBVT | DBV Technologies S.A. | 795.72M | -1.89% | 698,713 | 5.04M |
| 413 | PHAR | Pharming Group N.V. | 785.51M | 0.92% | 6,392 | 366.48M |
| 414 | DRUG | Bright Minds Biosciences Inc. | 781.58M | -1.82% | 156,403 | - |
| 415 | CADL | Candel Therapeutics, Inc. | 775.93M | 0.09% | 800,783 | - |
| 416 | PHR | Phreesia, Inc. | 773.27M | 9.54% | 1,126,137 | 495.59M |
| 417 | TENX | Tenax Therapeutics, Inc. | 769.87M | 0.98% | 2,092,742 | - |
| 418 | OCS | Oculis Holding AG | 765.72M | 2.02% | 370,877 | 1.45M |
| 419 | AHCO | AdaptHealth Corp. | 759.10M | -5.95% | 5,620,837 | 3.36B |
| 420 | SSII | SS Innovations International, Inc. | 754.50M | 1.62% | 36,997 | 48.47M |
| 421 | CTMX | CytomX Therapeutics, Inc. | 753.25M | 2.67% | 2,461,728 | 18.30M |
| 422 | RIGL | Rigel Pharmaceuticals, Inc. | 750.37M | 2.42% | 315,499 | 276.79M |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 747.40M | 6.26% | 219,391 | - |
| 424 | GYRE | Gyre Therapeutics, Inc. | 743.63M | 4.22% | 68,092 | 109.82M |
| 425 | CBIO | Crescent Biopharma, Inc. | 720.77M | 2.50% | 150,667 | 11.88M |
| 426 | HELP | Cybin Inc. | 719.64M | 4.59% | 1,737,859 | - |
| 427 | BBNX | Beta Bionics, Inc. | 715.34M | 12.69% | 1,274,149 | 119.01M |
| 428 | AGMB | AgomAb Therapeutics NV | 714.10M | 7.41% | 367,400 | - |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 713.84M | 1.41% | 1,843,044 | 389.32M |
| 430 | CBLL | CeriBell, Inc. | 713.70M | 3.07% | 229,479 | 95.07M |
| 431 | EVO | Evotec SE | 711.82M | 2.56% | 49,373 | 859.03M |
| 432 | NGNE | Neurogene Inc. | 711.19M | 0.25% | 103,220 | 925.00K |
| 433 | ALLO | Allogene Therapeutics, Inc. | 693.76M | 2.03% | 3,698,152 | 22.00K |
| 434 | IMMX | Immix Biopharma, Inc. | 691.97M | -3.38% | 1,604,783 | - |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 686.48M | -2.69% | 1,262,784 | 136.07M |
| 436 | ACHV | Achieve Life Sciences, Inc. | 682.68M | 1.53% | 712,458 | - |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 679.13M | 1.91% | 2,311,288 | 239.66M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 665.41M | 2.22% | 161,262 | 343.52M |
| 439 | RGNX | REGENXBIO Inc. | 661.45M | -4.96% | 1,387,934 | 174.48M |
| 440 | SOPH | SOPHiA GENETICS SA | 656.34M | 15.25% | 963,725 | 86.17M |
| 441 | STLN | Starling Oncology, Inc. | 653.28M | 28.46% | 6,621,747 | 587.24M |
| 442 | ANGO | AngioDynamics, Inc. | 648.51M | 3.84% | 405,570 | 320.17M |
| 443 | MDXG | MiMedx Group, Inc. | 632.60M | 3.83% | 1,361,859 | 355.17M |
| 444 | BWAY | BrainsWay Ltd. | 630.64M | -0.96% | 86,722 | 56.22M |
| 445 | FTH | Faeth Therapeutics, Inc. | 628.74M | -0.37% | 202,840 | - |
| 446 | TLRY | Tilray Brands, Inc. | 619.76M | 2.93% | 3,478,458 | 915.45M |
| 447 | NVCT | Nuvectis Pharma, Inc. | 617.42M | 0.64% | 171,936 | - |
| 448 | SPRY | ARS Pharmaceuticals, Inc. | 611.71M | 10.99% | 2,155,794 | 98.99M |
| 449 | ALT | Altimmune, Inc. | 598.98M | 2.33% | 4,505,570 | 36.00K |
| 450 | KIDS | OrthoPediatrics Corp. | 594.52M | -0.26% | 196,255 | 252.72M |
| 451 | VSTM | Verastem, Inc. | 592.27M | 14.04% | 4,319,009 | 87.53M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 584.57M | 2.51% | 271,635 | - |
| 453 | CRMD | CorMedix Inc. | 583.68M | -0.93% | 740,859 | 400.05M |
| 454 | ARVN | Arvinas, Inc. | 572.13M | 0.81% | 1,218,172 | 316.70M |
| 455 | ZURA | Zura Bio Limited | 566.66M | 4.47% | 955,896 | - |
| 456 | CTNM | Contineum Therapeutics, Inc. | 565.82M | -2.02% | 528,931 | - |
| 457 | SLN | Silence Therapeutics plc | 564.45M | 1.96% | 316,885 | 839.00K |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 561.97M | 1.90% | 346,898 | 88.24M |
| 459 | AUTL | Autolus Therapeutics plc | 561.56M | 5.50% | 2,035,534 | 92.62M |
| 460 | SGMT | Sagimet Biosciences Inc. | 559.47M | 3.66% | 1,113,003 | - |
| 461 | STTK | Shattuck Labs, Inc. | 557.47M | 1.54% | 894,438 | 1.00M |
| 462 | PRME | Prime Medicine, Inc. | 556.30M | 4.41% | 1,976,941 | 4.07M |
| 463 | CTEV | Claritev Corporation | 551.94M | 21.42% | 330,109 | 994.67M |
| 464 | MPLT | MapLight Therapeutics, Inc. | 551.86M | -8.36% | 432,478 | - |
| 465 | ARTV | Artiva Biotherapeutics, Inc. | 547.59M | -2.68% | 214,658 | 251.00K |
| 466 | CTKB | Cytek Biosciences, Inc. | 545.93M | 0.96% | 616,073 | 206.71M |
| 467 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.70M | -6.24% | 1,653,527 | 132.42M |
| 468 | BIOA | BioAge Labs, Inc. | 536.51M | 3.99% | 953,420 | 10.36M |
| 469 | ANL | Adlai Nortye Ltd. | 531.20M | -4.05% | 270,000 | 5.00M |
| 470 | FLGT | Fulgent Genetics, Inc. | 526.64M | 3.18% | 228,360 | 323.93M |
| 471 | DCTH | Delcath Systems, Inc. | 523.35M | -2.33% | 1,212,638 | 95.42M |
| 472 | VREX | Varex Imaging Corporation | 523.04M | 1.31% | 230,906 | 857.50M |
| 473 | RLMD | Relmada Therapeutics, Inc. | 518.16M | -8.01% | 2,125,224 | - |
| 474 | ASMB | Assembly Biosciences, Inc. | 513.62M | 0.87% | 119,771 | 71.10M |
| 475 | SRTA | Strata Critical Medical, Inc. | 512.22M | 3.58% | 1,314,476 | 255.98M |
| 476 | EVMN | Evommune, Inc. | 507.14M | 5.23% | 374,001 | 10.00M |
| 477 | NPCE | NeuroPace, Inc. | 505.61M | 6.69% | 201,037 | 99.53M |
| 478 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 479 | EIKN | Eikon Therapeutics, Inc. | 502.95M | 0.87% | 662,404 | - |
| 480 | EOLS | Evolus, Inc. | 501.32M | 2.43% | 1,631,993 | 316.49M |
| 481 | VALN | Valneva SE | 496.81M | 2.32% | 44,235 | 180.25M |
| 482 | PROK | ProKidney Corp. | 495.38M | - | 739,044 | 889.00K |
| 483 | AQST | Aquestive Therapeutics, Inc. | 494.34M | 0.51% | 1,860,322 | 50.27M |
| 484 | OVID | Ovid Therapeutics Inc. | 490.86M | -0.75% | 919,697 | 7.12M |
| 485 | SCTX | Scribe Therapeutics Inc. | 490.47M | 2.32% | 120,159 | 36.28M |
| 486 | BLSM | BlossomHill Therapeutics, Inc. | 490.30M | - | 1,757,634 | - |
| 487 | RZLT | Rezolute, Inc. | 489.95M | -0.21% | 986,250 | - |
| 488 | PRLD | Prelude Therapeutics Incorporated | 485.97M | 4.70% | 165,656 | 16.72M |
| 489 | KYTX | Kyverna Therapeutics, Inc. | 483.93M | 2.71% | 431,844 | - |
| 490 | IKT | Inhibikase Therapeutics, Inc. | 482.69M | 2.49% | 386,846 | 1.00 |
| 491 | CERS | Cerus Corporation | 473.58M | 1.29% | 3,484,714 | 221.55M |
| 492 | BNTC | Benitec Biopharma Inc. | 468.25M | 3.81% | 41,160 | - |
| 493 | NNNN | Anbio Biotechnology | 465.69M | 8.82% | 50,195 | 8.65M |
| 494 | QTTB | Q32 Bio Inc. | 464.32M | -3.70% | 513,378 | 53.74M |
| 495 | PBYI | Puma Biotechnology, Inc. | 459.93M | 9.73% | 683,332 | 231.24M |
| 496 | PRTA | Prothena Corporation plc | 458.61M | 2.10% | 481,846 | 54.53M |
| 497 | CABA | Cabaletta Bio, Inc. | 454.92M | 1.09% | 2,697,633 | - |
| 498 | NRC | NRC Health | 449.91M | 4.47% | 139,259 | 140.00M |
| 499 | EVH | Evolent Health, Inc. | 446.58M | 10.03% | 5,082,587 | 2.10B |
| 500 | OABI | OmniAb, Inc. | 446.52M | 37.50% | 2,681,397 | 38.46M |